Michael Stifelman, MD
Invited Faculty
Michael Stifelman, MD
Chairman, Department of Urology
Chief of Urologic Oncology
Hackensack University Medical Center
Hackensack, New Jersey

Expertise: Prostate Cancer, Kidney Cancer, Bladder Cancer, Ureter Cancer

  • Friday, February 19th 3:00–4:10 pm

    Kidney Session II – Retroperitoneal – Single Port


    The retroperitoneal approach is technically feasible and safe for treatment of various urologic diseases, resulting in better cosmetic outcomes, lower postoperative analgesic requirements, and faster convalescence than is available with conventional laparoscopy, we will discuss the advantage and disadvantage of retroperitoneal single-site robot-assisted partial nephrectomy (R-SSRPN) using the da Vinci Xi surgical system.